Common Stock, Shares, Outstanding of Compass Therapeutics, Inc. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Compass Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Compass Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 178,324,000, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Compass Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 178,324,000 +40,504,000 +29% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 177,572,000 +39,983,000 +29% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 138,282,000 +693,000 +0.5% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 138,282,000 +693,000 +0.5% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 137,820,000 +10,152,000 +8% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 137,589,000 +10,144,000 +8% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 137,589,000 +10,201,000 +8% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 137,589,000 +11,214,000 +8.9% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 127,668,000 +1,366,000 +1.1% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 127,445,000 +26,413,000 +26% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 127,388,000 +26,420,000 +26% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 126,375,000 +25,470,000 +25% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 126,302,000 +25,470,000 +25% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 101,032,000 +39,272,000 +64% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 100,968,000 +39,302,000 +64% 30 Jun 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 100,905,000 +49,592,000 +97% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 100,832,000 +49,611,000 +97% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 61,760,000 +10,735,730 +21% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 61,666,000 +10,769,167 +21% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 51,313,000 +46,313,000 +926% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 51,221,000 +44,187,000 +628% 31 Dec 2020 10-K 18 Mar 2022 2021 FY
Q3 2020 51,024,270 +46,024,270 +920% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 50,896,833 +45,896,833 +918% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 5,000,000 0 0% 31 Mar 2020 10-K 08 Jun 2020 2020 FY
Q4 2019 7,034,000 +2,034,000 +41% 31 Dec 2019 10-K 05 Mar 2021 2020 FY
Q3 2019 5,000,000 0 0% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q2
Q2 2019 5,000,000 0 0% 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 5,000,000 0 0% 31 Mar 2019 10-K 08 Jun 2020 2020 FY
Q4 2018 5,000,000 31 Dec 2018 10-Q 14 Feb 2019 2019 Q3
Q3 2018 5,000,000 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 5,000,000 30 Jun 2018 10-Q 14 Aug 2018 2019 Q1
Q1 2018 5,000,000 31 Mar 2018 10-K 01 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.